Structure | Chemical Name | CAS | MF |
|
4-AMINO-3,5-DICHLOROBENZYLAMINE
|
164648-75-3
|
C7H8Cl2N2
|
|
4-(aminomethyl)-N,N-dimethylbenzamide(SALTDATA: 1.27HCl 0.45H2O)
|
164648-76-4
|
C10H14N2O
|
|
4-(aminomethyl)-N-butylbenzamide
|
164648-77-5
|
C12H18N2O
|
|
4-CYANOPHENYL N,N-DIMETHYLSULFAMATE
|
164648-84-4
|
C9H10N2O3S
|
|
2H-Pyran-2-methanol,tetrahydro-5-methyl-6-(1-methylethyl)-,[2S-(2alpha,5alpha,6bta)]-(9CI)
|
164649-90-5
|
C10H20O2
|
|
KP 103
|
164650-44-6
|
C18H22F2N4O
|
|
S,S-Efinaconazole
|
164650-45-7
|
C18H22F2N4O
|
|
3-CHLORO-5-METHOXYBENZALDEHYDE
|
164650-68-4
|
C8H7ClO2
|
|
1,2,3,4-Tetrahydro-5-isoquinolinol Acetate
|
164653-60-5
|
C11H15NO3
|
|
DIBENZYL N,N-DIMETHYLPHOSPHORAMIDITE
|
164654-49-3
|
C16H20NO2P
|
|
(17β)-N-[2,5-Bis(trifluoroMethyl)phenyl]-3-oxo-androst-4-ene-17-carboxaMide
|
164656-19-3
|
C28H31F6NO2
|
|
(3S,3aS,5aS,6R,9aS,9bS)-3-[[[2,5-Bis(trifluoroMethyl)phenyl]aMino]carbonyl]dodecahydro-3a,6-diMethyl-7-oxo-1H-benz[e]indene-6-propanoic Acid
|
164656-20-6
|
C27H31F6NO4
|
|
(17β)-N-[2,5-Bis(trifluoroMethyl)phenyl]-3-oxo-4-azaandrost-5-ene-17-carboxaMide
|
164656-21-7
|
C27H30F6N2O2
|
|
Dihydrodutasteride
|
164656-22-8
|
C27H32F6N2O2
|
|
Dutasteride
|
164656-23-9
|
C27H30F6N2O2
|
|
3-AMINO-2,3-DIMETHYLBUTAN-1-OL
|
164656-83-1
|
C6H15NO
|
|
3-[[4-[2-[(3-Chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-1-propanol
|
164658-13-3
|
C18H18ClN5O
|
|
4-(3,4-Dimethoxyphenyl)-3-butene-1,2-diol
|
164661-12-5
|
C12H16O4
|
|
3-(Methylthio)-1-pyrrolidinecarboxylic acid,1,1-dimethylethylester
|
164666-07-3
|
C10H19NO2S
|
|
3-Amino-6-chloro-2-picoline
|
164666-68-6
|
C6H7ClN2
|
|
METHYL 2-FORMYL-4-METHYL-4H-FURO[3,2-B]PYRROLE-5-CARBOXYLATE
|
164667-56-5
|
C10H9NO4
|
|
Methyl 2-phenyl-4H-furo[3,2-b]pyrrole-5-carboxylate
|
164667-60-1
|
C14H11NO3
|
|
METHYL 4-METHYL-4H-FURO[3,2-B]PYRROLE-5-CARBOXYLATE
|
164667-61-2
|
C9H9NO3
|
|
4-(4-Methoxyphenyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-amine
|
164668-12-6
|
C12H12F3N3O
|
|
PKTPKKAKKL
|
164669-07-2
|
C53H99N15O12
|
|
4-PYRIDYLTHIOUREA
|
164670-44-4
|
C6H7N3S
|
|
2-CHLORO-3-PIPERAZIN-1-YL-QUINOXALINE
|
164670-46-6
|
C12H13ClN4
|
|
5-BROMO-2,3-DIMETHOXY-BENZONITRILE
|
164670-73-9
|
C9H8BrNO2
|
|
cyclorenierin A
|
164672-55-3
|
C21H26O3
|
|
Trachycladine A
|
164672-56-4
|
C11H14ClN5O3
|
|
Cyclopentanol, 1,2-dimethyl-5-(1-methylethyl)-, (1alpha,2ba,5ba)- (9CI)
|
164713-08-0
|
C10H20O
|
|
Cyclopentanol, 1,2-dimethyl-4-(1-methylethyl)-, (1alpha,2ba,4alpha)- (9CI)
|
164713-13-7
|
C10H20O
|
|
2-CYCLOHEX-3-EN-1-YL-1,3-THIAZOLIDINE-4-CARBOXYLIC ACID
|
164717-31-1
|
C10H15NO2S
|
|
Ethanone, 1-(4,5-dihydro-2-hydroxy-3-pyridinyl)- (9CI)
|
164718-06-3
|
C7H9NO2
|
|
Magnesium,2-Phenyl-1,3-Dioxolane,Bromide
|
164718-49-4
|
C9H12BrMgO2
|
|
3-OCTADECANOYLUMBELLIFERONE
|
164720-09-6
|
C27H40O4
|
|
1-(4-fluorophenyl)piperidin-4-amine
|
164721-12-4
|
C11H15FN2
|
|
6-Benzothiazolol, 4-(methoxy-3-pyridinylmethyl)-5,7-dimethyl-2-(methylamino)-
|
164721-61-3
|
C17H19N3O2S
|
|
6-Benzothiazolol, 5,7-dimethyl-2-(methylamino)-4-[(1-methylethoxy)-3-pyridinylmethyl]-
|
164721-63-5
|
C19H23N3O2S
|
|
2-AMINO-5-BROMO-3-HYDROXY-4-PICOLINE
|
164723-32-4
|
C6H7BrN2O
|
|
N4,N4,N4',N4'-tetra([1,1'-biphenyl]-4-yl)-[1,1'-biphenyl]-4,4'-diamine
|
164724-35-0
|
C60H44N2
|
|
4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineethanol dihydrochloride
|
164726-80-1
|
C19H25Cl3N2O
|
|
2-Propenamide, 2-methyl-3-(3-methyloxiranyl)- (9CI)
|
164727-46-2
|
C7H11NO2
|
|
Carbamic acid, (1,3-dimethyl-2-butenyl)-, 1,1-dimethylethyl ester (9CI)
|
164730-96-5
|
C11H21NO2
|
|
1H-2-Benzopyran,3,4-dihydro-3-methyl-3-phenyl-(9CI)
|
164731-59-3
|
C16H16O
|
|
N-[(4-methylphenyl)methyl]pyridin-2-amine
|
164733-64-6
|
C13H14N2
|
|
1-Azetidinecarboxamide,N-propyl-(9CI)
|
164735-74-4
|
C7H14N2O
|
|
7-BROMO-1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOLE
|
164736-47-4
|
C11H10BrN
|
|
2H-Pyrrole,5-(3-fluorophenyl)-3,4-dihydro-(9CI)
|
164737-45-5
|
C10H10FN
|
|
4-Pyrimidinecarboxaldehyde, 2-methoxy- (9CI)
|
164738-44-7
|
C6H6N2O2
|
|
1-(pyridazin-3-yl)ethanol
|
164738-47-0
|
C6H8N2O
|
|
4-(TRIMETHYLSILYL)PYRIMIDINE
|
164738-48-1
|
C7H12N2Si
|
|
1-Piperazineaceticacid,2-oxo-,ethylester(9CI)
|
164784-87-6
|
C8H14N2O3
|
|
2-(4-AMinopiperazin-1-yl)acetic acid
|
164785-11-9
|
C6H13N3O2
|
|
Ethanone, 1-(2-amino-5-ethylphenyl)-2-chloro- (9CI)
|
164788-90-3
|
C10H12ClNO
|
|
Ethanone, 1-(2-amino-5-propylphenyl)-2-chloro- (9CI)
|
164788-92-5
|
C11H14ClNO
|
|
Ethanone, 1-[2-amino-5-(1-methylethyl)phenyl]-2-chloro- (9CI)
|
164788-93-6
|
C11H14ClNO
|
|
4-oxopiperidine-3-carbaldehyde
|
164789-94-0
|
C6H9NO2
|
|
(R)-3-ETHOXY-PYRROLIDINE HYDROCHLORIDE
|
164790-65-2
|
C6H14ClNO
|
|
4-CHLORO-2,6-DIFLUOROPHENOL
|
164790-68-5
|
C6H3ClF2O
|
|
4-Thiomorpholinamine,3,3-dimethyl-(9CI)
|
164790-76-5
|
C6H14N2S
|
|
Bicyclo[1.1.1]pentane-1-carbonyl chloride, 3-bromo- (9CI)
|
164795-74-8
|
C6H6BrClO
|
|
Pyrido[4,3:4,5]pyrrolo[3,2-e]benzimidazole-2(1H)-thione, 3,6-dihydro-
|
164797-45-9
|
C12H8N4S
|
|
Pyrido[4,3:4,5]pyrrolo[3,2-e]benzimidazole-2(1H)-thione, 3,6-dihydro-7-phenyl-
|
164797-46-0
|
C18H12N4S
|
|
Pyrido[4,3:4,5]pyrrolo[3,2-e]benzimidazole, 1,6-dihydro-2-(methylthio)-
|
164797-47-1
|
C13H10N4S
|
|
Furo[3,4-b]furan-3-carboxylic acid, 4,6-dihydro- (9CI)
|
164797-59-5
|
C7H6O4
|
|
Propanamide, 2-(hydroxyimino)-N,N-dimethyl- (9CI)
|
164798-61-2
|
C5H10N2O2
|
|
3-Azabicyclo[3.1.0]hexane-6-carboxamide,6-amino-,(1alpha,5alpha,6beta)-(9CI)
|
164799-13-7
|
C6H11N3O
|
|
exo-3-Methyl-6-amino-3-azabicyclo[3.1.0]hexane
|
164799-15-9
|
C6H12N2
|
|
Trachycladine B
|
164803-17-2
|
C11H14N4O4
|
|
N-UNDECANE-D24
|
164858-54-2
|
C11H24
|
|
(R)-(+)-2-[2-(DIPHENYLPHOSPHINO)PHENYL]-4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE
|
164858-78-0
|
C24H24NOP
|
|
(4R)-4-(1,1-diMethylethyl)-2-[2-(diphenylphosphino)phenyl]-4,5-dihydro-Oxazole
|
164858-79-1
|
C25H26NOP
|
|
2-Methyl-1-(3,4-dimethoxyphenyl)-1-(2-dimethylamino-4,5-dimethoxypheny l)propane
|
164859-57-8
|
C22H31NO4
|
|
Urinary Trypsin Inhibitor
|
164859-77-2
|
C40H66N14O9S
|
|
HDBTU
|
164861-52-3
|
C12H16F6N5O2P
|
|
(2R,3R)-2-(2,4-DIFLUOROPHENYL)-3-(4-METHYLENEPIPERIDIN-1-YL)-1-(1H-1,2,4-TRIAZOL-1-YL)BUTAN-2-OL
|
164905-19-5
|
C18H22F2N4O
|
|
L-(+)-SWAINSONINE
|
164907-52-2
|
C8H15NO3
|
|
Glucoprotamin
|
164907-72-6
|
|
|
Reaction products of 4-nonylphenol, 1-dodecanethiol and formaldehyde
|
164907-73-7
|
|
|
Fluorescent brightener 378
|
164908-53-6
|
C30H26O2
|
|
3-NITROSALICYLIC ACID SODIUM SALT
|
164915-53-1
|
C7H4NNaO5
|
|
7-Nitro-3(2H)-benzofuranone
|
164915-57-5
|
C8H5NO4
|
|
Cyclopentanecarboxylic acid, 2-amino-4-fluoro-, (1alpha,2alpha,4alpha)- (9CI)
|
164916-31-8
|
C6H10FNO2
|
|
Cyclopentanecarboxylic acid, 2-(methylamino)-, cis- (9CI)
|
164916-43-2
|
C7H13NO2
|
|
3-Furancarboxylicacid,4-aminotetrahydro-,(3R,4S)-rel-(9CI)
|
164916-44-3
|
C5H9NO3
|
|
3-Thiophenecarboxylicacid,4-aminotetrahydro-,cis-(9CI)
|
164916-45-4
|
C5H9NO2S
|
|
cis-Methyl 4-N-Boc-amino-pyrrolidine-3-carboxylate
|
164916-49-8
|
C11H20N2O4
|
|
(CIS)-1-BENZYL 2-METHYL 4-OXOCYCLOPENTANE-1,2-DICARBOXYLATE
|
164916-54-5
|
C15H16O5
|
|
CIS-1-BENZYL-3,4-PYRROLIDINEDICARBOXYLIC ACID
|
164916-63-6
|
C13H15NO4
|
|
N-Bromoisocyanuric acid monosodium salt
|
164918-61-0
|
C3H3BrN3NaO3
|
|
1-(3-Methylbenzoyl)pyrrolidine, 97%
|
164918-75-6
|
C12H15NO
|
|
Ethanone, 1-(4-amino-2-oxido-1,2,5-oxadiazol-3-yl)- (9CI)
|
164926-69-6
|
C4H5N3O3
|
|
1,2,5-Oxadiazole-3-carboxamide,4-amino-N-methyl-,2-oxide(9CI)
|
164926-70-9
|
C4H6N4O3
|
|
1,2,5-Oxadiazole-3-carboxylicacid,4-amino-,ethylester,2-oxide(9CI)
|
164926-74-3
|
C5H7N3O4
|
|
4-Piperidineacetonitrile,1-methyl-(9CI)
|
164926-88-9
|
C8H14N2
|
|
2-(4-METHYL-PIPERAZIN-1-YL)-THIOACETAMIDE
|
164926-91-4
|
C7H15N3S
|
|
1H-Pyrazole-5-carboxylic acid, 4,5-dihydro-, methyl ester (9CI)
|
164928-01-2
|
C5H8N2O2
|
|
GAMMA,GAMMA-DIMETHYL-ALPHA-TRIFLUOROMETHYL-GAMMA-BUTYROLACTONE
|
164929-15-1
|
C7H9F3O2
|
|
2(1H)-Pyridinone, 3,4-diamino-5,6-dimethyl-
|
164930-92-1
|
C7H11N3O
|